In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?

Gonorrhea may become untreatable, and new treatment options are essential. We investigated the in vitro activity of the first fluoroketolide, solithromycin. Clinical Neisseria gonorrhoeae isolates and reference strains (n = 246), including the two extensively drug-resistant strains H041 and F89 and...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Golparian, Daniel, Fernandes, Prabhavathi, Ohnishi, Makoto, Jensen, Jörgen S., Unemo, Magnus
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2012
נושאים:
Susceptibility
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3346660/
https://ncbi.nlm.nih.gov/pubmed/22354296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00036-12
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים